A randomised, placebo-controlled, double blind, crossover trial on the effect of a 20:1 cannabidiol: Δ9-tetrahydrocannabinol medical cannabis product on neurocognition, attention, and mood
Article in European Neuropsychopharmacology (March 2024)
The most recent citing publications are shown below. View all 67 publications that cite this research output on Dimensions.
Article in European Neuropsychopharmacology (March 2024)
Article in Reviews in Agricultural Science (April 2023)
Article in STUDIES IN HEALTH SCIENCES (April 2023)